Propel Health Appoints Amy Koch as Senior Vice President, Client Services in Medical Affairs

Amy Koch Joins Propel Health Medical Affairs as Senior Vice President, Client Services

Propel Health Medical Affairs (PHMA), a full-service scientific communications agency operating within the broader Propel Health ecosystem, has announced the appointment of Amy Koch as Senior Vice President, Client Services. This strategic leadership addition reflects the organization’s continued investment in strengthening its client engagement model and enhancing its ability to deliver high-impact scientific communications solutions to pharmaceutical and biotechnology partners.

In her new role, Amy Koch will oversee the Client Services function at PHMA, a critical division responsible for managing relationships with clients and ensuring the successful delivery of integrated medical communications programs. She will work closely with pharmaceutical and biotech organizations across the product lifecycle, helping to design and implement strategies that effectively communicate scientific data, support clinical development, and ultimately improve patient outcomes. Her responsibilities will also include driving operational excellence, aligning cross-functional teams, and ensuring that client needs are met with precision, consistency, and measurable value.

The appointment comes at a time when demand for high-quality, data-driven scientific communications is increasing across the life sciences industry. As therapies become more complex and regulatory expectations evolve, companies are seeking partners who can provide not only content expertise but also strategic insight and seamless execution. PHMA aims to address these needs by offering comprehensive services that span publications, medical affairs strategy, and stakeholder engagement—areas where Amy Koch brings significant expertise.

With more than two decades of experience in medical affairs, scientific communications, and publications, Amy Koch has built a strong reputation as a leader capable of navigating the complexities of the pharmaceutical landscape. Throughout her career, she has successfully managed multimillion-dollar client portfolios and led high-performing teams across a diverse range of therapeutic areas. Her experience includes supporting product launches, lifecycle management initiatives, and evidence dissemination strategies, making her well-equipped to guide clients through critical inflection points in their development and commercialization journeys.

Koch is widely recognized for her collaborative leadership style and her ability to foster trust-based relationships with clients and internal stakeholders alike. Her approach emphasizes transparency, accountability, and a deep understanding of client objectives, enabling her to deliver tailored solutions that align with both scientific and business goals. Colleagues and clients frequently highlight her hands-on involvement, attention to detail, and commitment to excellence as key factors in her success.

In addition to her leadership capabilities, Koch is known for her ability to scale teams and build organizational infrastructure that supports sustained growth. She has a proven track record of recruiting, mentoring, and retaining top talent, while also implementing processes and systems that enhance efficiency and performance. This combination of people leadership and operational expertise will be particularly valuable as PHMA continues to expand its capabilities and client base.

Commenting on the appointment, Jeff Keller, President of Propel Health Medical Affairs, expressed strong confidence in Koch’s ability to contribute to the organization’s ongoing success. He noted that her unique blend of client leadership, strategic vision, and operational discipline aligns closely with PHMA’s mission to deliver best-in-class scientific communications services. Keller also emphasized her proven ability to deepen client partnerships and drive measurable outcomes, describing her as a key addition to the leadership team.

Keller further highlighted the importance of aligning client services with broader organizational goals, noting that Koch’s experience in scaling teams and managing complex engagements will help PHMA continue to deliver consistent, high-quality results. Her appointment is expected to enhance the agency’s ability to respond to evolving client needs while maintaining a strong focus on innovation and excellence.

From a broader organizational perspective, Mark Fleischer, Chief Executive Officer of Propel Health, underscored the company’s commitment to growth and talent development. He stated that the addition of experienced leaders like Amy Koch is a central component of Propel Health’s strategy to expand its capabilities and strengthen its position in the healthcare communications market. Fleischer emphasized that the organization is dedicated to providing its teams with the tools, resources, and support needed to succeed in a highly competitive and rapidly evolving industry.

Fleischer also expressed enthusiasm about Koch’s potential contributions, noting that her expertise and leadership will play an important role in shaping the future direction of the company. As Propel Health continues to grow, attracting and retaining top talent remains a key priority, and Koch’s appointment reflects this ongoing commitment.

Overall, the addition of Amy Koch as Senior Vice President, Client Services represents a significant milestone for Propel Health Medical Affairs. Her extensive experience, leadership capabilities, and client-centric approach are expected to enhance the organization’s ability to deliver strategic, high-quality scientific communications solutions. As PHMA continues to evolve and expand, Koch’s role will be instrumental in driving client success, fostering long-term partnerships, and supporting the company’s broader growth objectives within the life sciences sector.

About Propel Health Medical Affairs
Propel Health Medical Affairs brings together strategy, scientific content, and innovation to transform clinical behaviors. The team delivers services across a brand’s lifecycle, including early phase medical strategy, publication planning, congress and advisory board management, medical education, scientific communications, and stakeholder engagement. With deep therapeutic knowledge and a commitment to scientific rigor, Propel Health Medical Affairs enables clients to translate complex data into clear, credible insights that advance patient care and inform confident decision-making. Learn more at MedicalAffairs.PropelHealth.com .

Propel Health Medical Affairs is part of the Propel Health network, which includes: Propel Health Engagements , the industry-leading provider of speaker bureau solutions; Propel Health Communications , an award-winning, full-service promotional and medical communications agency that builds strategic solutions that propel brands—and health—forward; and Propel Health Patient Experience , a trusted partner of the life sciences industry for authentic engagement with patients, caregivers, and advocacy groups to fuel brand success.

Source Link:https://www.businesswire.com/